In December 2020, Cardiol announced the appointment of CRO Worldwide Clinical Trials ("Worldwide") for its Phase II/III trial in high-risk patients hospitalized with COVID-19. In February 2021, the Corporation received proceeds of $7,879,820 on the exercise of 2,424,560 warrants with an exercise price of $3.25, and $503,068 on the exercise of 201,227 warrants with an exercise price of $2.50. In addition, there were a total of 916,666 stock option exercises, resulting in cumulative proceeds of $2,604,648. Dr ...

Exhibit 99.1 CARDIOL THERAPEUTICS INC. CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS THREE MONTHS ENDED MARCH 31, 2022 (EXPRESSED IN CANADIAN DOLLARS) (UNAUDITED) Cardiol Therapeutics Inc. Condensed Interim Consolidated Statements of Financial Position (Expressed in Canadian Dollars) Unaudited | --- | --- | --- | --- | --- | --- | |----------------------------------------------------------------|-------|-------|--------------------------|-------|-----------------------------| | ASSETS | | | As at Marc ...

CARDIOE | --- | --- | --- | --- | --- | --- | |------------------------|-------|----------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | The Next Generation of CBD | | | | | TSX: CRDL OTCQX: CRTPF | | | | | | Disclaimer In this presentation, all amounts are in Canadian dollars, unless otherwise indicated. Any graphs, tables or other information in this presentation demonstrating the historical performance of Cardiol or any other entity contained in ...

BARDIOL | --- | --- | --- | --- | --- | --- | |-------|-------|-------|----------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | The Next Generation of CBD | | | | | | | | | | | | | | | | | | | | | | | | Disclaimer In this presentation, all amounts are in Canadian dollars, unless otherwise indicated. Any graphs, tables or other information in this presentation demonstrating the historical performance of Cardiol or any other entity contained in this present ...